Chemical Name: 4-(3-Butoxy-4-methoxyphenyl)methyl-2-imidazolidone
Biological ActivityWidely used inhibitor of cyclic nucleotide phosphodiesterase, selective for PDE4 (IC50 = 2.0 μM).
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Differential modulation of tissue function and therapeutic potential of selective inhibitors of cyclic nucleotide phosphodiesterase isoenzymes.
Ahluwalia and Nicholson et al.
Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase.
Soderling et al.
The identification of a new cyclic nucleotide phosphodiesterase activity in human and guinea-pig cardiac ventricle.
Reeves et al.
Citations for Ro 20-1724
The citations listed below are publications that use Tocris products. Selected citations for Ro 20-1724 include:
3 Citations: Showing 1 - 3
Rapid remodeling of tight junctions during paracellular diapedesis in a human model of the blood-brain barrier.
Authors: Winger Et al.
J Immunol 2014;193:2427
Phosphodiesterase 4 inhibition impairs cocaine-induced inhibitory synaptic plasticity and conditioned place preference.
Authors: Zhong Et al.
Evaluation of cellular dielectric spectroscopy, a whole-cell, label-free technology for drug discovery on Gi-coupled GPCRs.
Authors: Peters Et al.
J Biomol Screen 2007;12:312
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for Ro 20-1724
There are currently no reviews for this product. Be the first to review Ro 20-1724 and earn rewards!
Have you used Ro 20-1724?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image